CL2016001076A1 - (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis. - Google Patents
(aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.Info
- Publication number
- CL2016001076A1 CL2016001076A1 CL2016001076A CL2016001076A CL2016001076A1 CL 2016001076 A1 CL2016001076 A1 CL 2016001076A1 CL 2016001076 A CL2016001076 A CL 2016001076A CL 2016001076 A CL2016001076 A CL 2016001076A CL 2016001076 A1 CL2016001076 A1 CL 2016001076A1
- Authority
- CL
- Chile
- Prior art keywords
- aza
- inhibitors
- pyridopyrazolopyrimidinones
- indazolopyrimidinones
- fibrinolosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
Abstract
COMPUESTOS DERIVADOS DE (AZA) PIRIDOPIRAZOLOPIRIMIDINONAS E INDAZOLOPIRIMIDINONAS, COMO INHIBIDORES DE FIBRINOLISIS; PROCESO PARA SU PREPARACION; COMPUESTOS INTERMEDIARIOS; MEDICAMENTO QUE LOS COMPRENDE, UTIL PARA EL TRATAMIENTO Y/O PROFILAXIS DE SANGRADO AGUDO Y RECURRENTE EN PACIENTES CON O SIN TRASTORNOS DE SANGRADO HEREDITARIOS O ADQUIRIDOS SUBYACENTES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13191642 | 2013-11-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2016001076A1 true CL2016001076A1 (es) | 2016-12-09 |
Family
ID=49517406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2016001076A CL2016001076A1 (es) | 2013-11-05 | 2016-05-05 | (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis. |
Country Status (29)
Country | Link |
---|---|
US (3) | US9598417B2 (es) |
EP (1) | EP3066100B1 (es) |
JP (1) | JP6431061B2 (es) |
KR (1) | KR102312780B1 (es) |
CN (1) | CN105683194B (es) |
AP (1) | AP2016009175A0 (es) |
AR (1) | AR098292A1 (es) |
AU (1) | AU2014345771B2 (es) |
CA (1) | CA2929378C (es) |
CL (1) | CL2016001076A1 (es) |
CR (1) | CR20160332A (es) |
CU (1) | CU24361B1 (es) |
DO (1) | DOP2016000102A (es) |
EA (1) | EA029373B1 (es) |
ES (1) | ES2732305T3 (es) |
GT (1) | GT201600084A (es) |
HK (1) | HK1223940A1 (es) |
IL (1) | IL244645B (es) |
MA (1) | MA39018A1 (es) |
MX (1) | MX370419B (es) |
PE (1) | PE20160934A1 (es) |
PH (1) | PH12016500828A1 (es) |
SG (1) | SG11201602133RA (es) |
TN (1) | TN2016000161A1 (es) |
TW (1) | TWI657089B (es) |
UA (1) | UA117504C2 (es) |
UY (1) | UY35809A (es) |
WO (1) | WO2015067549A1 (es) |
ZA (1) | ZA201602311B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY35809A (es) * | 2013-11-05 | 2015-05-29 | Bayer Pharma AG | (aza)piridopirazolopirimidinonas e indazolopirimidinonas y sus usos |
AU2015342021B2 (en) * | 2014-11-03 | 2020-02-27 | Bayer Pharma Aktiengesellschaft | Piperidinylpyrazolopyrimidinones and their use |
WO2016173948A1 (en) * | 2015-04-30 | 2016-11-03 | Bayer Pharma Aktiengesellschaft | Indazolopyrimidinones as fibrinolysis inhibitors |
WO2017007917A1 (en) * | 2015-07-07 | 2017-01-12 | Mast Therapeutics, Inc. | Polyoxyethylene/polyoxypropylene copolymers and fibrinolytic inhibitors, uses thereof and compositions |
EP3318563A1 (en) | 2016-11-07 | 2018-05-09 | Sanofi | Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders |
CN110590673A (zh) * | 2019-09-02 | 2019-12-20 | 南通大学 | 一种4-氯-7-甲基-1h-吲唑及其化学合成方法 |
US11654057B2 (en) | 2020-04-09 | 2023-05-23 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
KR20230142746A (ko) * | 2021-02-05 | 2023-10-11 | 시노허브 파마슈티컬 씨오., 엘티디 | 플라스민 억제제, 이의 제조 방법 및 이의 용도 |
WO2022261154A1 (en) | 2021-06-09 | 2022-12-15 | Eli Lilly And Company | Substituted fused azines as kras g12d inhibitors |
US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
WO2023194222A1 (en) | 2022-04-05 | 2023-10-12 | Socpra Sciences Santé Humaines S.E.C. | Inhibitors of chymase for use in the selective resolution of thrombi in thrombotic or thromboembolic disorders |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2192559A5 (en) * | 1972-07-17 | 1974-02-08 | Ugine Kuhlmann | Pyrimidino (1,2-b) indazole derivs - inters for dyes and pharmaceuticals, from 3-aminoindazoles and beta-ketone derivs |
JP5000504B2 (ja) | 2004-07-30 | 2012-08-15 | フェリング ビー.ブイ. | トラネキサム酸製剤 |
AR059224A1 (es) * | 2006-01-31 | 2008-03-19 | Jerini Ag | Compuestos para la inhibicion de integrinas y uso de estas |
ES2494390T3 (es) * | 2008-06-06 | 2014-09-15 | Sanofi | Derivados macrocíclicos de urea y de sulfamida como inhibidores de TAFIa |
US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
TW201040166A (en) | 2009-04-07 | 2010-11-16 | Astrazeneca Ab | Isoxazol-3(2H)-one analogs as therapeutic agents |
WO2012047156A1 (en) * | 2010-10-04 | 2012-04-12 | Astrazeneca Ab | Isoxazol-3(2h)-one analogs as plasminogen inhibitors and their use in the treatment of fibrinolysis related diseases |
AU2011331301A1 (en) * | 2010-11-15 | 2013-05-23 | Katholieke Universiteit Leuven | Antiviral condensed heterocyclic compounds |
WO2012082947A1 (en) * | 2010-12-16 | 2012-06-21 | Irm Llc | Compounds and compositions as tgr5 agonists |
JP5886868B2 (ja) * | 2010-12-16 | 2016-03-16 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | 置換ピリミド[1,2−b]インダゾールおよびPI3K/AKT経路のモジュレーターとしてのそれらの使用 |
UY35809A (es) * | 2013-11-05 | 2015-05-29 | Bayer Pharma AG | (aza)piridopirazolopirimidinonas e indazolopirimidinonas y sus usos |
WO2016173948A1 (en) * | 2015-04-30 | 2016-11-03 | Bayer Pharma Aktiengesellschaft | Indazolopyrimidinones as fibrinolysis inhibitors |
-
2014
- 2014-10-31 UY UY0001035809A patent/UY35809A/es not_active Application Discontinuation
- 2014-11-03 EA EA201690935A patent/EA029373B1/ru not_active IP Right Cessation
- 2014-11-03 AP AP2016009175A patent/AP2016009175A0/en unknown
- 2014-11-03 MX MX2016005969A patent/MX370419B/es active IP Right Grant
- 2014-11-03 KR KR1020167014622A patent/KR102312780B1/ko active IP Right Grant
- 2014-11-03 PE PE2016000586A patent/PE20160934A1/es unknown
- 2014-11-03 CU CU2016000062A patent/CU24361B1/es unknown
- 2014-11-03 JP JP2016527398A patent/JP6431061B2/ja not_active Expired - Fee Related
- 2014-11-03 AU AU2014345771A patent/AU2014345771B2/en not_active Ceased
- 2014-11-03 SG SG11201602133RA patent/SG11201602133RA/en unknown
- 2014-11-03 TW TW103137976A patent/TWI657089B/zh not_active IP Right Cessation
- 2014-11-03 EP EP14793523.3A patent/EP3066100B1/en active Active
- 2014-11-03 ES ES14793523T patent/ES2732305T3/es active Active
- 2014-11-03 CR CR20160332A patent/CR20160332A/es unknown
- 2014-11-03 TN TN2016000161A patent/TN2016000161A1/en unknown
- 2014-11-03 UA UAA201605980A patent/UA117504C2/uk unknown
- 2014-11-03 CA CA2929378A patent/CA2929378C/en active Active
- 2014-11-03 WO PCT/EP2014/073529 patent/WO2015067549A1/en active Application Filing
- 2014-11-03 MA MA39018A patent/MA39018A1/fr unknown
- 2014-11-03 CN CN201480060660.7A patent/CN105683194B/zh not_active Expired - Fee Related
- 2014-11-04 AR ARP140104130A patent/AR098292A1/es not_active Application Discontinuation
- 2014-11-05 US US14/533,915 patent/US9598417B2/en active Active
-
2016
- 2016-03-17 IL IL244645A patent/IL244645B/en active IP Right Grant
- 2016-04-06 ZA ZA2016/02311A patent/ZA201602311B/en unknown
- 2016-05-04 PH PH12016500828A patent/PH12016500828A1/en unknown
- 2016-05-05 GT GT201600084A patent/GT201600084A/es unknown
- 2016-05-05 CL CL2016001076A patent/CL2016001076A1/es unknown
- 2016-05-05 DO DO2016000102A patent/DOP2016000102A/es unknown
- 2016-10-27 HK HK16112345.9A patent/HK1223940A1/zh not_active IP Right Cessation
-
2017
- 2017-01-26 US US15/416,651 patent/US10098883B2/en active Active
-
2018
- 2018-08-10 US US16/101,250 patent/US10668071B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016001076A1 (es) | (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis. | |
CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
NI201600071A (es) | Compuestos de inhibidor de autotaxina | |
EA201890204A1 (ru) | Антибактериальные соединения | |
CL2018000596A1 (es) | Nuevos compuestos bicíclicos como inhibidores de la atx | |
EA201990043A1 (ru) | Антибактериальные соединения | |
BR112016018408A2 (pt) | moléculas de anticorpo à lag-3 e usos das mesmas | |
BR112017007379A2 (pt) | moléculas de anticorpo para pd-l1 e usos das mesmas | |
CL2015002855A1 (es) | Derivados de oxopiridina sustituida. | |
EA201790575A1 (ru) | Триазолопиразиноны в качестве ингибиторов pde1 | |
BR112015015891A8 (pt) | Composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica | |
CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
EA201792157A1 (ru) | Имидазопиразиноны в качестве ингибиторов pde1 | |
NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
SV2017005412A (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
CL2015002692A1 (es) | Novedosos compuestos de bencenosulfonamida, método para sintetizarlos y uso de los compuestos en medicina y en cosméticos. | |
ECSP16008797A (es) | Derivados de heterobicicloaril como inhibidores rorc2 y métodos de uso de los mismos | |
EA201790312A1 (ru) | Комбинации лекарственных средств для лечения множественной миеломы | |
BR112015023074A2 (pt) | agentes de ligação-met e uso dos mesmos | |
BR112015027477A8 (pt) | bolus, seus usos, e kit | |
CL2016001210A1 (es) | Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis. | |
BR112017024163A2 (pt) | compostos bicíclicos | |
EA201691108A1 (ru) | Хиназолин-thf-амины в качестве ингибиторов pde1 | |
BR112016012248A2 (pt) | método de tratamento de nefropatia | |
BR112017010845A2 (pt) | uso de ligandos do receptor sigma em osteoartrite |